FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

376809003: Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3501530013 Methimazole 5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3501531012 Thiamazole 5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3683502016 Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Thiamazole 5 mg oral tablet Is a Product containing only thiamazole (medicinal product) true Inferred relationship Some
Thiamazole 5 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Thiamazole 5 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Thiamazole 5 mg oral tablet Has basis of strength substance (attribute) Thiamazole true Inferred relationship Some 1
Thiamazole 5 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Thiamazole 5 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Thiamazole 5 mg oral tablet Has precise active ingredient Thiamazole true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

GB English

Back to Start